about
Defining synthetic surfaces for human pluripotent stem cell cultureThe directed differentiation of human iPS cells into kidney podocytesA continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells.New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.Gonocyte-Sertoli cell interactions during development of the neonatal rodent testis.Generation of induced pluripotent stem cells from human kidney mesangial cellsA novel role for an RNA polymerase III subunit POLR3G in regulating pluripotency in human embryonic stem cells.Gene expression variability as a unifying element of the pluripotency network.Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors.Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells.Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.The hypoxia-inducible factor renders cancer cells more sensitive to vitamin C-induced toxicity.Scaffolds for 3D in vitro culture of neural lineage cells.Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.Deep-transcriptome and ribonome sequencing redefines the molecular networks of pluripotency and the extracellular space in human embryonic stem cells.Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling.Enrichment and purging of human embryonic stem cells by detection of cell surface antigens using the monoclonal antibodies TG30 and GCTM-2.Developmental response by Leydig cells to acidic and basic fibroblast growth factor.Requirement for heparan sulphate proteoglycans to mediate basic fibroblast growth factor (FGF-2)-induced stimulation of Leydig cell steroidogenesis.Restricted ethnic diversity in human embryonic stem cell lines.Application of a chromogenic bioassay procedure for the measurement of the proliferation of endothelial cells in vitro under the influence of the effects of steroid hormones and growth factors.Expression of a novel factor, short-type PB-cadherin, in Sertoli cells and spermatogenic stem cells of the neonatal rat testis.Cell reprogramming: Into the groove.Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells.Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming.Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces.Cell surface markers for the identification and study of human naive pluripotent stem cells.Flow cytometric analysis of human pluripotent stem cells.Isolation, characterization, and differentiation of human embryonic stem cells.Physiological oxygen culture reveals retention of metabolic memory in human induced pluripotent stem cells.Single-Cell Profiling Identifies Key Pathways Expressed by iPSCs Cultured in Different Commercial MediaEvidence that heparin binding autocrine factors modulate testosterone production by the adult rat Leydig cellThyroid hormone down-regulates neural cell adhesion molecule expression and affects attachment of gonocytes in Sertoli cell-gonocyte coculturesA single dose of Di-(2-ethylhexyl) phthalate in neonatal rats alters gonocytes, reduces sertoli cell proliferation, and decreases cyclin D2 expressionPreparation of defined human embryonic stem cell populations for transcriptional profilingThree-dimensional differentiation of human pluripotent stem cell-derived neural precursor cells using tailored porous polymer scaffoldsThe application of cell surface markers to demarcate distinct human pluripotent statesDesigner macrophages: Pitfalls and opportunities for modelling macrophage phenotypes from pluripotent stem cells
P50
Q27014667-AE42D465-4B86-429F-836C-FD15ED83CEC4Q27316230-1DD1429D-3448-4114-898D-1E96EBD63D80Q33515036-09A064B4-DCB0-425B-99EC-927C4B869292Q33626268-CED15B1F-533B-43E4-9EEB-4E5098742220Q34007877-72D086B3-FC50-426A-855A-7EDBEB7E8BDEQ34184650-A49CA9BE-C507-4BD9-8CF9-626086589EDDQ34214154-F4A43ECD-1ADC-49D2-B46D-C42ECBC039ADQ34246105-19F6A5B7-57AB-4A76-8AE9-194A852CCA14Q34596358-7AE21351-53A3-4A64-A70E-B2F23D667015Q35127500-E399C067-4C14-4043-82D1-2630027E645BQ35947502-E82D68EA-844B-4DE6-B694-1F9E081CA7DDQ35993428-F764D1E8-DD04-4CEC-848F-A311FB5AC050Q36266493-CEE1E552-1A8E-4F93-A0C6-18CFEDDAAF8AQ37563440-3A260122-E261-4FEC-BD8B-59463BD6628AQ38750686-ACF02A20-5362-446B-B58E-03E16621C8EFQ39144719-4B2E9903-DF44-4843-9DD5-B83BBF468D40Q39449912-B2F8FA07-C8B7-4C93-918B-BCC15FE8E323Q39958444-AB6602B3-3DC5-4191-915E-254E0334994EQ40288358-316EEA54-EF87-411E-A3B8-F64E39F36EB8Q42439878-09DAE622-B52D-423B-9BFD-B62D498EDB77Q42479092-5B480973-8EDC-49F8-AE34-07F4B2239F0EQ42812882-A1F21311-F6BF-4D68-B014-F924A9EA9546Q42816701-78B36748-8E94-4714-AD1B-FAFEBE107E13Q44358339-9190E94E-729A-49F7-95A7-996DC5F47E85Q44756863-2173316B-D36D-46A9-A177-DEDE8949D0A8Q47969653-96F66F61-C91E-4FF5-9223-61F0875A494AQ48053163-370C4EAC-0B0D-41A3-962C-DED815F0D5ABQ48239414-FE8D432B-A9C3-4345-8AEA-5DF83AD743C7Q49943811-EAD0D3D1-8F44-4B53-A69F-EC0EA84A8DA6Q51858370-DEEA5A87-70BB-468E-8E16-5B64E9553A03Q52095736-0D72FD54-E9A9-4538-B4AF-98737D8D377FQ55434077-D40D4F82-DD38-46B1-BA06-EB13B482587FQ58711068-64794CE4-C092-48D7-9E29-C7819ED303C3Q60923224-F6FFB0CC-2196-4B04-BCC3-4882583F07E3Q73769308-C76E09FF-442E-4EDD-93AF-75C425FBAE10Q74037449-DE7B2CC6-5A3A-41AD-A567-4CFF42D23DCBQ84469848-F6A4015C-10D9-4396-A9B7-87EF53AC4BDDQ90696325-0C87145E-D549-484C-805B-663462A0741CQ91606599-BB3BD9BC-AA23-415D-91C0-4C3EEDB15BA3Q93213881-528DE908-C34A-4C94-962F-00AE6E063013
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrew L Laslett
@ast
Andrew L Laslett
@en
Andrew L Laslett
@es
Andrew L Laslett
@nl
Andrew L Laslett
@sl
type
label
Andrew L Laslett
@ast
Andrew L Laslett
@en
Andrew L Laslett
@es
Andrew L Laslett
@nl
Andrew L Laslett
@sl
prefLabel
Andrew L Laslett
@ast
Andrew L Laslett
@en
Andrew L Laslett
@es
Andrew L Laslett
@nl
Andrew L Laslett
@sl
P106
P21
P31
P496
0000-0003-4729-8193